COMBINATION VEGFR2 THERAPY WITH MTOR INHIBITORS

摘要

The present disclosure relates to improved methods of treating neoplastic disorders by combining VEGFR2 specific inhibitor treatment with mTOR inhibitors. The present disclosure also relates to methods of preventing the development of VEGFR2 resistance.